TIL
Instil Bio, Inc.NASDAQHealthcare$8.03+0.00%ClosedMarket Cap: $54.5M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
0.50
P/S
0.00
EV/EBITDA
-2.00
DCF Value
$-11.77
FCF Yield
-63.8%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-55.9%
ROA
-35.1%
ROIC
-39.5%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $0.00 | -Infinity% | $-9.6M | $-8.2M | $-1.21 | — |
| FY 2025 | $0.00 | -Infinity% | $-52.9M | $-71.4M | $-10.70 | — |
| Q3 2025 | $0.00 | -Infinity% | $-15.0M | $-13.6M | $-2.01 | — |
| Q2 2025 | $0.00 | NaN% | $-23.4M | $-21.4M | $-3.24 | — |
| Q1 2025 | $0.00 | NaN% | $-30.6M | $-28.2M | $-4.32 | — |
| Q4 2024 | $0.00 | -Infinity% | $-11.5M | $-11.9M | $-1.82 | — |
| FY 2024 | $0.00 | NaN% | $-73.5M | $-74.1M | $-11.39 | — |
| Q3 2024 | $0.00 | NaN% | $-23.6M | $-23.0M | $-3.54 | — |
| Q2 2024 | $0.00 | NaN% | $-14.1M | $-14.9M | $-2.29 | — |
| Q1 2024 | $0.00 | -Infinity% | $-19.7M | $-24.3M | $-3.74 | — |
| Q4 2023 | $0.00 | -Infinity% | $-12.9M | $-12.9M | $-1.99 | — |
| FY 2023 | $0.00 | NaN% | $-159.2M | $-156.1M | $-24.00 | — |